As cyclin D1-CDK4/6 is crucial for G1 cell cycle progression and generation of neoplastic cells, targeting CDK4/6 could be effective for ESCC patients [29,30,31]. The gene discussed is CDK4; the disease is esophageal squamous cell carcinoma.